NCT01468896 2026-04-29Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1/2 Active not recruiting23 enrolled 11 charts